Gene therapy on trial.
Marshall
E
E
D000256:Adenoviridae / Q000235:genetics* / Q000276:immunology; D026683:Advisory Committees; D000818:Animals; D002986:Clinical Trials as Topic / Q000592:standards*; D003550:Cystic Fibrosis / Q000235:genetics / Q000628:therapy; D026724:Ethical Review; D035082:Federal Government; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000009:adverse effects; D005822:Genetic Vectors / Q000009:adverse effects; D033161:Government Regulation; D006801:Humans; D007249:Inflammation; D015850:Interleukin-6 / Q000097:blood; D008099:Liver; D009316:National Institutes of Health (U.S.); D033281:Nontherapeutic Human Experimentation; D009954:Ornithine Carbamoyltransferase / Q000235:genetics; D020163:Ornithine Carbamoyltransferase Deficiency Disease; D035842:Research Subjects; D014481:United States; D014486:United States Food and Drug Administration
D015850:Interleukin-6; D009954:Ornithine Carbamoyltransferase